These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36472095)

  • 1. Targeting the tubulin C-terminal tail by charged small molecules.
    Li S; Mori M; Yang M; Elfazazi S; Hortigüela R; Chan P; Feng X; Risinger A; Yang Z; Oliva MÁ; Fernando Díaz J; Fang WS
    Org Biomol Chem; 2022 Dec; 21(1):153-162. PubMed ID: 36472095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tubulin C-terminal tail on mechanical properties of microtubule.
    Nowroz S; Nasrin SR; Kabir AMR; Yamashita T; Kusumoto T; Taira J; Tani M; Ichikawa M; Sada K; Kakugo A
    Biochem Biophys Res Commun; 2024 Apr; 706():149761. PubMed ID: 38479245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
    Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
    Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
    Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
    Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward Discovery of Novel Microtubule Targeting Agents: A SNAP-tag-Based High-Content Screening Assay for the Analysis of Microtubule Dynamics and Cell Cycle Progression.
    Berges N; Arens K; Kreusch V; Fischer R; Di Fiore S
    SLAS Discov; 2017 Apr; 22(4):387-398. PubMed ID: 28328318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What tubulin drugs tell us about microtubule structure and dynamics.
    Amos LA
    Semin Cell Dev Biol; 2011 Dec; 22(9):916-26. PubMed ID: 22001382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
    Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
    J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding sites of microtubule-stabilizing agents.
    Field JJ; Díaz JF; Miller JH
    Chem Biol; 2013 Mar; 20(3):301-15. PubMed ID: 23521789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel class of tubulin inhibitors with promising anticancer activities.
    Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
    Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule targeting agents: from biophysics to proteomics.
    Calligaris D; Verdier-Pinard P; Devred F; Villard C; Braguer D; Lafitte D
    Cell Mol Life Sci; 2010 Apr; 67(7):1089-104. PubMed ID: 20107862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel and potent small-molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations.
    Liu G; Jiao Y; Huang C; Chang P
    J Comput Aided Mol Des; 2019 Jul; 33(7):659-664. PubMed ID: 31165955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Combretastatin A-4 Inspired Inhibitors of Tubulin Polymerization: An Update.
    Baytas SN
    Curr Med Chem; 2022; 29(20):3557-3585. PubMed ID: 34986762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tale of 12 Tails: Katanin Severing Activity Affected by Carboxy-Terminal Tail Sequences.
    Lindsay KA; Abdelhamid N; Kahawatte S; Dima RI; Sackett DL; Finegan TM; Ross JL
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of tubulin inhibitors that interact with the colchicine binding site.
    Lu Y; Chen J; Xiao M; Li W; Miller DD
    Pharm Res; 2012 Nov; 29(11):2943-71. PubMed ID: 22814904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
    Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
    Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress on Microtubule Degradation Agents.
    Zhang C; Zhao M; Wang G; Li Y
    J Med Chem; 2023 Oct; 66(19):13354-13368. PubMed ID: 37748178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel Diarylamide
    Liu X; Pang XJ; Liu Y; Liu WB; Li YR; Yu GX; Zhang YB; Song J; Zhang SY
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.